SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-22-265369
Filing Date
2022-10-19
Accepted
2022-10-19 17:10:47
Documents
2

Document Format Files

Seq Description Document Type Size
1 425 d382653d425.htm 425 829430
2 GRAPHIC g382653dsp130.jpg GRAPHIC 4157
  Complete submission text file 0001193125-22-265369.txt   836952
Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Filed by) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Subject) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-39279 | Film No.: 221319203
SIC: 2836 Biological Products, (No Diagnostic Substances)